• 15th Annual Mtg


    It is with deep regret, and out of an abundance of caution, that the ISIA Board of Directors voted to CANCELL the April 22 & 23, 2020 Annual Meeting in Brisbane, Australia.

    Given the business impacts of the ongoing COVID-19 epidemic, including several corporate and government travel bans, we deemed this action prudent.

    ISIA Members:
    We will be in further contact with you regarding our Annual Business meeting which must still be arranged. Once this process is determined it will be listed on the ISIA website.

    We look forward to seeing you in Denver, Colorado in 2021.

  • TRACES NT Updates

    Defra continues to refine information regarding TRACES NT.

    We have been notified that BCPs are receiving some CHED-As with box I.28 – ‘Transporter’ not completed.

    Please make sure that you complete this box, otherwise the necessary link to HMRC systems will not be established and your consignment will be delayed. 

    Click the link below for more detailed information.

    Learn More >

  • UK Withdrawal Agreement Finalized

    The UK Withdrawal Agreement Bill has been agreed by Parliament and received Royal Assent, therefore the UK will leave the European Union on 31st January 2020!
    A transition period  will be in place until 31 December, 2020.
    There are several updates regarding the transition period for the serum industry. which we encourage you to read carefully.  Click below to obtain this important information.

    Learn More >

  • ISIA on

    LinkedIn will be our go-to place to post the latest regulatory updates and ISIA information.  Click on the link below to "follow us" on LinkedIn to ensure you get this important information!

    Learn More >

International Serum Industry Association

Members of the International Serum industry Association are collectors, processors and users of animal serum and animal derived products. These products are used extensively in the growth of cells in culture for research and in the production of diagnostic kits, vaccines and biotherapeutic molecules.

The ISIA Mission


ISIA shall establish, promote and assure compliance with uncompromised standards of excellence and ethics in the business practices of the global animal serum and animal derived products supply industry.

Safety and Safe Use

Our primary focus will continue to be on safety and safe use of serum and animal derived products through proper origin traceability, and truth in labeling, and appropriate standardization and oversight.


We will work to educate stakeholders on the scientific foundation of the safe use of serum and animal derived products.

Why Get ISIA Traceability Certification?

Dr. Rosemary Versteegen explains in this video.

Learn More
About ISIA

Want to know more about ISIA or attend important meetings where we will be presenting?  See the list below to see upcoming ISIA presentations world-wide.

Cell Series UK

Jenny Murray -attending
29-31 October, 2019 - London, England

BIT's 13th World Congress of Regernerative Medicine & Stem Cell

Rosemary Versteegen presenting
1-3 November, 2019 - Dalian, Liaoning, China

3rd Annual Biologics World Nordic 2020

Rosemary Versteegen presenting
17-19 March, 2020 - Copenhagen, Denmark

Cell & Gene Therapy Innovation Leaders Summit 

Jenny Murray presenting
5 and 6 February, 2020 - Berlin Germany

18th IDDST2020

Rosemary Versteegen presenting
15-17 July, 2020 - Amsterdam, The Netherlands

Join The ISIA Global Network Today